Female-Specific Risk Factors for CVD: The Impact of Adverse Pregnancy Outcomes on Subsequent Mental Health and CVD Risk

女性特定的 CVD 危险因素:不良妊娠结局对后续心理健康和 CVD 风险的影响

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Female-specific and female-predominant risk factors provide opportunities to improve cardiovascular disease (CVD) prevention and screening in women. Pregnancy complications are risk markers for future CVD revealed through the cardiometabolic “stress test” of pregnancy, which can be leveraged for early CVD prevention before the onset of established risk factors (chronic hypertension, hypercholesterolemia, type 2 diabetes). Women with a history of preeclampsia (a condition involving high blood pressure during pregnancy) or preterm delivery (<37 weeks’ gestation) have twice the risk of future CVD. Mental health conditions, such as posttraumatic stress disorder (PTSD) and depression, are twice as common in women as in men and are also associated with increased CVD risk. Although existing studies and anecdotal evidence suggest that acute adverse pregnancy outcomes (APOs; preeclampsia and preterm delivery) can constitute a traumatic event for some women and precipitate the development of mental health conditions after pregnancy, rigorous epidemiologic studies are lacking. The extent to which APOs and mental health conditions may jointly contribute to CVD in women is also unknown. This project will draw on the strengths of complementary populations and methodologic approaches, including observational epidemiologic analyses within the Nurses’ Health Study 2 and 3 (NHS2/3) prospective cohort studies and leveraging electronic health records (EHR) from the Mass General Brigham health system for both quantitative prediction modeling using machine learning and to recruit patients with recent acute APOs to participate in qualitative interviews. This research will address the gaps in the literature by: 1) evaluating the extent to which the increased CVD risk observed among women with a history of APOs is accounted for by the development of mental health conditions after pregnancy using data from NHS2/3; 2) identifying clinically relevant risk and resilience factors from the EHR that influence the risk of developing mental health conditions after an acute APO; and 3) elucidating the relationship between APOs and subsequent PTSD secondary to APO-related trauma through semi-structured qualitative patient interviews. In addition to generating new insights into the accumulation of CVD risk across a woman’s life, this proposal will provide crucial training for my development into an independent investigator by cultivating new skills in: 1) machine learning using EHR data, 2) qualitative research, and 3) psychiatric epidemiology. Given my strong background in reproductive and cardiovascular epidemiology, my world-class mentoring team, and personalized training plan to advance my skillset, I am well equipped to accomplish the proposed research. The training, mentorship, and protected time provided by this Career Development Award will uniquely position me as a leading epidemiologist equipped to improve the cardiovascular health of women.
项目摘要/摘要 女性特异性和女性优势风险因素提供了改善心血管的机会 女性的疾病(CVD)预防和筛查。怀孕并发症是未来的风险标志 通过心脏代谢的“应力测试”揭示了CVD,可以将其用于早期CVD 在既定危险因素发作之前的预防(慢性高血压,高胆固醇血症,2型) 糖尿病)。具有先兆子痫病史的妇女(这种疾病涉及高血压 怀孕)或早产(妊娠<37周)的未来CVD风险是两倍。心理健康 妇女中的病变后应激障碍(PTSD)和抑郁症等疾病是抑郁症的两倍 就像男性一样,也与CVD风险增加有关。虽然现有研究和轶事 有证据表明,急性不良怀孕结局(APO;先兆子痫和早产)可以 构成某些妇女的创伤事件,并为心理健康状况的发展而珍贵 怀孕后,缺乏严格的流行病学研究。 APO和心理健康的程度 妇女中可能共同促进CVD的条件也未知。这个项目将借鉴优势 互补种群和方法论方法,包括观察性流行病学 护士健康研究2和3(NHS2/3)的分析前瞻性研究和利用 来自大规模杨海洋卫生系统的电子健康记录(EHR),用于两种定量 使用机器学习进行预测建模并招募最近急性APO的患者参与 定性访谈。这项研究将通过:1)评估文献中的差距 在具有APO史的女性中观察到的CVD风险增加的原因是 使用NHS2/3的数据在怀孕后心理健康状况的发展; 2)在临床上识别 EHR的相关风险和弹性因素影响发展心理健康的风险 急性Apo后的条件; 3)阐明APO与随后的PTSD之间的关系 通过半结构化定性患者访谈继发于APO相关的创伤。 除了对CVD风险在女性的生活中积累的新见解外,该提议 通过培养新技能,将为我的发展提供至关重要的培训: 1)使用EHR数据的机器学习,2)定性研究,3)精神病流行病学。给了我 生殖和心血管流行病学,我的世界一流的心理团队以及 个性化的培训计划以提高我的技能,我有能力完成拟议的研究。 该职业发展奖提供的培训,精通和受保护的时间将是唯一的 将我定位为能够改善女性心血管健康的领先流行病学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Jacqueline Stuart其他文献

Jennifer Jacqueline Stuart的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Jacqueline Stuart', 18)}}的其他基金

Female-Specific Risk Factors for CVD: The Impact of Adverse Pregnancy Outcomes on Subsequent Mental Health and CVD Risk
女性特定的 CVD 危险因素:不良妊娠结局对后续心理健康和 CVD 风险的影响
  • 批准号:
    10853320
  • 财政年份:
    2022
  • 资助金额:
    $ 14.32万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

N,N-Dimethylacetamide Vaginal Self-nanoemulsifying Drug Delivery System for the Prevention or Preterm Birth
N,N-二甲基乙酰胺阴道自纳米乳化给药系统用于预防或早产
  • 批准号:
    10620777
  • 财政年份:
    2022
  • 资助金额:
    $ 14.32万
  • 项目类别:
N,N-Dimethylacetamide Vaginal Self-nanoemulsifying Drug Delivery System for the Prevention or Preterm Birth
N,N-二甲基乙酰胺阴道自纳米乳化给药系统用于预防或早产
  • 批准号:
    10412252
  • 财政年份:
    2022
  • 资助金额:
    $ 14.32万
  • 项目类别:
IMMUNE RESPONSES IN THE MOTHER-INFANT DYAD INDUCED BY FETAL SURGERY, AND ASSOCIATIONS WITH PREMATURITY
胎儿手术引起的母婴二元体的免疫反应以及与早产的关联
  • 批准号:
    10113537
  • 财政年份:
    2020
  • 资助金额:
    $ 14.32万
  • 项目类别:
Predicting Pulmonary and Cardiac Morbidity in Preterm Infants with Deep Learning
通过深度学习预测早产儿的肺部和心脏发病率
  • 批准号:
    10198019
  • 财政年份:
    2019
  • 资助金额:
    $ 14.32万
  • 项目类别:
Predicting Pulmonary and Cardiac Morbidity in Preterm Infants with Deep Learning
通过深度学习预测早产儿的肺部和心脏发病率
  • 批准号:
    10646498
  • 财政年份:
    2019
  • 资助金额:
    $ 14.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了